pharmaphorum

FEBRUARY 11, 2021

If pharma companies are to live up to their decades-old patient-centric promises then marketing budgets need to move from brands and franchises to omnichannel customer-centric teams, according to one digital transformation leader. Pharma companies really need to become patient, but also healthcare professional, centric.

Pharma Companies 104

Pharma Companies Marketing Branding Life Science 104

Pharma Marketing Network

OCTOBER 1, 2024

Pharma marketing strategies have evolved significantly over the years, adapting to changes in technology, regulatory landscapes, and consumer behavior. This article provides a comprehensive overview of the various facets of pharmaceutical marketing, from its historical evolution to future trends.

Marketing 52

Marketing Pharma Companies Regulation Production 52

Pharma Marketing Network

OCTOBER 25, 2024

In an era wher Pharmaceutical digital marketing is in the middle of a rapid transformation. For pharma marketing executives , reaching audiences in meaningful, personalized ways has never been more critical. To put it simply, digital marketing in pharma is the bridge to reach these audiences effectively.

Marketing 52

Marketing Compliance Branding Engineer 52

Pharma Marketing Network

OCTOBER 29, 2024

In today’s fast-paced digital world, healthcare digital marketing is no longer optional for pharma brands—it’s essential. This article explores effective strategies to help pharma marketing executives navigate the digital landscape successfully.

Marketing 52

Marketing Branding Compliance Engineer 52

Pharma Marketing Network

NOVEMBER 6, 2024

The world of digital marketing in pharma is evolving rapidly. Pharma marketing executives face the unique challenge of staying compliant while engaging audiences in meaningful ways. So, how can digital marketing truly revolutionize the pharma space? Use personalization to tailor your content.

Marketing 52

Marketing Compliance Branding Regulation 52

pharmaphorum

NOVEMBER 1, 2021

Daiichi Sankyo has launched its oncolytic virus therapy Delytact in Japan – its first world market – as a treatment for malignant glioma, an aggressive form of brain cancer. million yen (around $12,500) per dose, according to a Pharma Japan report.

Genetic Engineering 122

Genetic Engineering Clinical Trials Clinical Trials Trials 122

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. But what does it take to implement these innovations?

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

Pharma Marketing Network

DECEMBER 13, 2024

Table of Contents Sr# Headings 1 Introduction 2 The Evolution of Healthcare Advertising 3 Top Healthcare Advertising Strategies 4 Harnessing Digital for Pharma Success 5 Conclusion Introduction Healthcare advertising has never been more dynamic, especially in the pharma world. Top Healthcare Advertising Strategies 1.

Marketing 52

Marketing Branding Compliance Engineer 52

Pharma Marketing Network

DECEMBER 13, 2024

Table of Contents Sr# Headings 1 Introduction 2 Understanding Cost-Per-Action in Pharma 3 Why CPA is Perfect for Pharma Marketing 4 Implementing CPA Strategies Effectively 5 Conclusion Introduction The pharmaceutical industry is no stranger to high stakes and competitive markets. Why CPA is Perfect for Pharma Marketing 1.

Marketing 52

Marketing Branding Compliance Regulation 52

pharmaphorum

JUNE 14, 2021

Delytact is an engineered herpes simplex virus type 1 (HSV-1) designed to selectively replicate in – and kill – tumour cells without affecting normal tissues, and was discovered by scientists led by Prof Tomoki Todo of the University of Tokyo.

Clinical Trials 119

Clinical Trials Clinical Trials Trials Pharma Companies 119

pharmaphorum

APRIL 1, 2021

Generally speaking, there was always a correlation between the sales rep effectiveness and the market results. The industry moved to “multi-channel marketing” by adding headquarter-driven email on top of the face-to-face sales rep visits and congresses. Isn’t this a great time to incentivise based on the behaviour that really matters?

Sales 86

Sales Marketing Life Science Pharma Companies 86

pharmaphorum

JUNE 10, 2022

Pharma’s evolving role in patient care. The digital revolution has already reshaped the commercial engine of biopharma companies. However, pharma’s commercial leaders are uniquely positioned to drive the strategic digital shift in patient care journeys. Partner to deliver at speed.

Marketing 133

Marketing Engineer Bioinformatics Regulation 133

pharmaphorum

FEBRUARY 13, 2022

Toxicity is a major contributor to drug failure accounting for two-thirds of post-market drug withdrawals and arid a fifth of failures during clinical testing. “If successful, this could lead to a much-needed transformation in drug development speed, safety and cost,” said Ciechanover. .

Drugs 98

Drugs In-Vivo In-Vitro Pharma Companies 98

XTalks

DECEMBER 20, 2023

In 2024, pharma companies and emerging biotechs will improve candidate safety profiles and reduce off-target effects by exploiting predictive intelligence unlocked by AI,” she predicts. The global wearable medical devices market size was valued at $73.77 Sometimes you can have the technology and the market is not ready.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

Pharma Marketing Network

MARCH 29, 2022

Pharmaceutical companies have been successful for decades with a siloed marketing strategy. Rep-led field engagement, television advertising, and digital marketing have all been planned, executed, and measured separately, but customer expectations are changing fast.

Marketing 52

Marketing Pharma Companies Sales Life Science 52

pharmaphorum

AUGUST 23, 2021

The vaccine may be a latecomer to the COVID-19 vaccine arsenal, but its approval signals the potential of DNA vaccines and is a boost to companies working in this space. The company also says that it can update the vaccine very easily to deal with mutations in the virus.

DNA 98

DNA Vaccination Vaccine Genetic Engineering 98

pharmaphorum

FEBRUARY 16, 2022

Feskens will join CEO and founder Matt Lowe and CCO, Jason Brown on the Global Executive Board and brings a broad experience from local and International commercial roles in large, mid-size and start up pharma companies. About performance-io.

Pharma Companies 52

Pharma Companies Marketing Engineer Production 52

pharmaphorum

JANUARY 5, 2023

Like many industries, the pharmaceutical labour market has felt and will continue to feel the impacts of the COVID-19 pandemic moving into 2023 and beyond. A new operating model for pharma shifted priorities and forced companies to rethink their organisational strategies. Final takeaway.

Life Science 90

Life Science Pharmacy Marketing Sales 90

pharmaphorum

FEBRUARY 11, 2022

Sun says because of this, Komodo engineered solutions or apps that “do certain things for end-users applied against the Healthcare Map.”. This technology can be particularly beneficial for rare disease organisations as they often don’t have data scientists at their disposal or full-stack engineers. ” About the interviewee.

Life Science 105

Life Science Engineer Development Big Data 105

pharmaphorum

DECEMBER 1, 2022

3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to reach a value of $3.48 Academia – Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering. Billion by 2028. Who Should Attend?

In-Vitro 52

In-Vitro Scientist Engineer Gene Therapy 52

Pharmaceutical Technology

JUNE 22, 2023

Data exclusivity has been a heated point of debate in the recently announced pharmaceutical reform, which aims to shorten it from eight years to six, drawing the ire of pharma companies. Hence, some experts remain unsure of how the scheme will incentivise the development of new drugs to fight AMR.

Drugs 130

Drugs Development Pharma Companies Marketing 130

pharmaphorum

JUNE 23, 2021

Pharmaceutical sales and marketing operations have been forced to follow a steep learning curve as they adjust to operating within the rapidly evolving and hugely changed landscape caused by the pandemic. For pharma companies, this will mean exploring platforms that can maximize these relationships acknowledged Edouard.

Life Science 102

Life Science Doctor Doctors Sales 102

pharmaphorum

APRIL 26, 2022

With more research being published, there has arrived greater interest in how individual microbiomes could influence health and there is now a growing market of prebiotic, probiotic and postbiotic commercial products based on the links being made to various health conditions.

Containment 115

Containment Development Production Drugs 115

pharmaphorum

AUGUST 4, 2020

If the data support European approval, the sensor would be the company’s first product on the market. However VivoPlex said that like many other medical device and pharma companies, it will wait until the capacity becomes available after the COVID-19 lockdown.

Development 52

Development Production Pharma Companies Engineer 52

pharmaphorum

APRIL 1, 2021

In the past couple of years, Turbine worked with a number of big pharma companies, including Bayer, and has also started building its own pipeline, including a target delivering new biological insight in PARP inhibitor resistance. “We About the interviewees.

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

The Pharma Data

JANUARY 24, 2021

.–( BUSINESS WIRE )– Faze Medicines , a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced that it has appointed Philip Vickers, Ph.D., Preclinical and clinical programs at Northern Biologics were acquired by big pharma companies in 2020.

Medicine 52

Medicine Pharma Companies Gene Therapy Development 52

pharmaphorum

MARCH 18, 2021

Pharma companies and sales reps need to adapt to their customer behaviours to stay relevant”. Pharma companies and their sales reps need to adapt to their customer behaviours to stay relevant. He is a digital transformation leader with experience across different companies and industries. But it doesn’t stop there.

Sales 52

Sales Pharma Companies Engineer Life Science 52

pharmaphorum

JANUARY 7, 2021

ImaginAb has signed a deal with Pfizer, which it hopes will help it to gather information necessary for approval of its tumour imaging agent as a medical device in markets in the US and other countries.

Immune Response 53

Immune Response Doctor Doctors Pharma Companies 53

pharmaphorum

JULY 8, 2022

Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. Reites comments that “our partnership strategy is to align with companies that have an equal view of the market. Novel digital endpoints. About the author.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

Placebo Control

JANUARY 12, 2014

Because the costs of bringing a drug to market are so high, time from discovery to marketing is so long, and the chances of success of any individual drug are so grim, betting on any individual drug is foolish, according to Stein. A tweet from V.S. Schulz pointed me to a post on Derek Lowe's In the Pipeline blog.

Development 40

Development Drugs Pharma Companies Engineer 40

XTalks

JUNE 14, 2024

The $40 million will come from the Venture Ontario Fund, which is dedicated to helping Ontario life sciences companies and biomanufacturers innovate, grow and compete in global markets. The new funding will help the province’s researchers and companies develop innovative life-saving medicines and technologies of tomorrow.

Life Science 52

Life Science Insulin Research Manufacturing 52

pharmaphorum

JANUARY 25, 2022

We think customer data should cover the complete ecosystem, with flexible usage, real-time updates and insights embedded in CRM, to help pharma companies be more successful in their engagement with their stakeholders.” ” About the interviewee. About Veeva Systems.

Sales 105

Sales Production Life Science Nurses 105

pharmaphorum

AUGUST 31, 2021

For the innovators and early adopters of the life sciences industry, engineering a regulatory-grade ECA can be daunting. However, if history is any indication, pharma companies have been risk-averse when it comes to fully immersing itself into the expanded use of RWE in our development efforts.

Clinical Trials 89

Clinical Trials Clinical Trials Life Science Trials 89

pharmaphorum

OCTOBER 26, 2022

Every pharma company developing treatments for new diseases is contributing to some degree to better global health. Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. About Chiesi Group.

Development 96

Development Trials Marketing Life Science 96

pharmaphorum

FEBRUARY 15, 2021

Chugai Pharmaceutical’s UK innovation lead, Martin Ellgood explores the challenges pharma companies face when devising innovation strategies. We have a large footprint in Japan, and as part of the Roche Group, we have a great tradition of bringing innovative medicines to market in Europe.

Pharma Companies 89

Pharma Companies Engineer Branding Sales 89

XTalks

JULY 10, 2023

This is not a side project for our engineers or the IT team. There’s a good symbiotic partnership in collectively going to the market and figuring out a problem. Bayer is helping us achieve global reach, but we are very much focused on the details of execution, operation, technology and product market fit.

Life Science 52

Life Science Cardiology Regulation Pharma Companies 52

Placebo Control

MAY 30, 2013

I suppose this a consequence of ASCO's members-only focus: getting the oncologists themselves to address patient accrual is a bit like asking NASCAR drivers to tackle the problems of aerodynamics, engine design, and fuel chemistry. Market research is sometimes useful. Nonetheless, every year, a few brave souls do try.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Pharma Companies 40